Search research articles
Contact Us
Filters
Showing results (91-100 of 112) with videos related to
Page
of 12
Sort By:
European Journal of Clinical Investigation
|
March 15, 2008
Magnetic resonance guided focused ultrasound surgery. Ablation of soft tissue at bone-muscle interface in a porcine model
D Kopelman, Y Inbar, A Hanannel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1995
Bone marrow-sparing and prevention of alopecia by AS101 in non-small-cell lung cancer patients treated with carboplatin and etoposide
B Sredni, M Albeck, T Tichler, et al.
Cancer Research
|
February 15, 1994
Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes
A Gabizon, R Catane, B Uziely, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1992
Modulation of neovascularization and metastasis by species of heparin
I Vlodavsky, R Ishai-Michaeli, M Mohsen, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy
|
June 1, 1987
Combined immunotherapy and chemotherapy with tuftsin plus cyclophosphamide in the treatment of non-small-cell carcinoma of the lung
E Warner, A Sulkes, E Gez, et al.
Cancer Treatment Reports
|
November 1, 1979
Analysis and interpretation of response rates for anticancer drugs
Y J Lee, R Catane, M Rozencweig, et al.
Journal of Cellular Biochemistry. Supplement
|
April 13, 2000
BRCA1 and BRCA2 mutation carriers as potential candidates for chemoprevention trials
E Levy-Lahad, M Krieger, O Gottfeld, et al.
Spine
|
June 1, 1987
Experimental neoplastic spinal cord compression: evoked potentials, edema, prostaglandins, and light and electron microscopy
T Siegal, T Z Siegal, U Sandbank, et al.
The Journal of Urology
|
February 25, 2000
An implant releasing the gonadotropin hormone-releasing hormone agonist histrelin maintains medical castration for up to 30 months in metastatic prostate cancer
B Chertin, I M Spitz, T Lindenberg, et al.
European Journal of Cancer & Clinical Oncology
|
December 1, 1989
Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study
A Gabizon, T Peretz, A Sulkes, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 112) with videos related to
Sort By:
Page
of 12
European Journal of Clinical Investigation
|
March 15, 2008
Magnetic resonance guided focused ultrasound surgery. Ablation of soft tissue at bone-muscle interface in a porcine model
D Kopelman, Y Inbar, A Hanannel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1995
Bone marrow-sparing and prevention of alopecia by AS101 in non-small-cell lung cancer patients treated with carboplatin and etoposide
B Sredni, M Albeck, T Tichler, et al.
Cancer Research
|
February 15, 1994
Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes
A Gabizon, R Catane, B Uziely, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1992
Modulation of neovascularization and metastasis by species of heparin
I Vlodavsky, R Ishai-Michaeli, M Mohsen, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy
|
June 1, 1987
Combined immunotherapy and chemotherapy with tuftsin plus cyclophosphamide in the treatment of non-small-cell carcinoma of the lung
E Warner, A Sulkes, E Gez, et al.
Cancer Treatment Reports
|
November 1, 1979
Analysis and interpretation of response rates for anticancer drugs
Y J Lee, R Catane, M Rozencweig, et al.
Journal of Cellular Biochemistry. Supplement
|
April 13, 2000
BRCA1 and BRCA2 mutation carriers as potential candidates for chemoprevention trials
E Levy-Lahad, M Krieger, O Gottfeld, et al.
Spine
|
June 1, 1987
Experimental neoplastic spinal cord compression: evoked potentials, edema, prostaglandins, and light and electron microscopy
T Siegal, T Z Siegal, U Sandbank, et al.
The Journal of Urology
|
February 25, 2000
An implant releasing the gonadotropin hormone-releasing hormone agonist histrelin maintains medical castration for up to 30 months in metastatic prostate cancer
B Chertin, I M Spitz, T Lindenberg, et al.
European Journal of Cancer & Clinical Oncology
|
December 1, 1989
Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study
A Gabizon, T Peretz, A Sulkes, et al.
Page
of 12